Works matching AU Yokoyama, Toshihide

Results: 62
    1

    Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.

    Published in:
    2017
    By:
    • Satoshi Ikeda;
    • Hiroshige Yoshioka;
    • Satoshi Ikeo;
    • Mitsunori Morita;
    • Naoyuki Sone;
    • Takashi Niwa;
    • Akihiro Nishiyama;
    • Toshihide Yokoyama;
    • Akimasa Sekine;
    • Takashi Ogura;
    • Tadashi Ishida;
    • Ikeda, Satoshi;
    • Yoshioka, Hiroshige;
    • Ikeo, Satoshi;
    • Morita, Mitsunori;
    • Sone, Naoyuki;
    • Niwa, Takashi;
    • Nishiyama, Akihiro;
    • Yokoyama, Toshihide;
    • Sekine, Akimasa
    Publication type:
    journal article
    2
    3

    Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 6, p. 519, doi. 10.1016/j.cllc.2023.05.008
    By:
    • Kimio Yonesaka;
    • Hidetoshi Hayashi;
    • Atsushi Nakamura;
    • Yuki Sato;
    • Koichi Azuma;
    • Shinya Sakata;
    • Motoko Tachihara;
    • Satoshi Ikeda;
    • Toshihide Yokoyama;
    • Kentaro Ito;
    • Yukihiro Yano;
    • Hirotaka Matsumoto;
    • Haruko Daga;
    • Akito Hata;
    • Kazuko Sakai;
    • Yasutaka Chiba;
    • Kazuto Nishio;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawal
    Publication type:
    Article
    4

    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

    Published in:
    2020
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Makio, Takeshi;
    • Hara, Satoshi
    Publication type:
    journal article
    5

    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.

    Published in:
    Clinical Lung Cancer, 2019, v. 20, n. 2, p. 134, doi. 10.1016/j.cllc.2018.10.008
    By:
    • Ninomiya, Takashi;
    • Ishikawa, Nobuhisa;
    • Inoue, Koji;
    • Kubo, Toshio;
    • Yasugi, Masayuki;
    • Shibayama, Takuo;
    • Maeda, Tadashi;
    • Fujitaka, Kazunori;
    • Kodani, Masahiro;
    • Yokoyama, Toshihide;
    • Kuyama, Shoichi;
    • Ochi, Nobuaki;
    • Ueda, Yutaka;
    • Miyoshi, Seigo;
    • Kozuki, Toshiyuki;
    • Amano, Yoshihiro;
    • Kubota, Tetsuya;
    • Sugimoto, Keisuke;
    • Bessho, Akihiro;
    • Ishii, Tomoya
    Publication type:
    Article
    6

    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.

    Published in:
    2018
    By:
    • Ninomiya, Takashi;
    • Ishikawa, Nobuhisa;
    • Inoue, Koji;
    • Kubo, Toshio;
    • Yasugi, Masayuki;
    • Shibayama, Takuo;
    • Maeda, Tadashi;
    • Fujitaka, Kazunori;
    • Kodani, Masahiro;
    • Yokoyama, Toshihide;
    • Kuyama, Shoichi;
    • Ochi, Nobuaki;
    • Ueda, Yutaka;
    • Miyoshi, Seigo;
    • Kozuki, Toshiyuki;
    • Amano, Yoshihiro;
    • Kubota, Tetsuya;
    • Sugimoto, Keisuke;
    • Bessho, Akihiro;
    • Ishii, Tomoya
    Publication type:
    journal article
    7

    Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403.

    Published in:
    2017
    By:
    • Naohiro Oda;
    • Eiki Ichihara;
    • Katsuyuki Hotta;
    • Kiichiro Ninomiya;
    • Takashi Ninomiya;
    • Toshio Kubo;
    • Daisuke Minami;
    • Toshi Murakami;
    • Toshihide Yokoyama;
    • Daijiro Harada;
    • Shoichi Kuyama;
    • Hirohisa Ichikawa;
    • Koji Inoue;
    • Daizo Kishino;
    • Masaaki Inoue;
    • Nagio Takigawa;
    • Takuo Shibayama;
    • Shingo Harita;
    • Mitsune Tanimoto;
    • Katsuyuki Kiura
    Publication type:
    journal article
    8

    A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 7, p. 805, doi. 10.1093/jjco/hyae044
    By:
    • Nogami, Naoyuki;
    • Kubo, Toshio;
    • Bessho, Akihiro;
    • Sakugawa, Makoto;
    • Ikeo, Satoshi;
    • Yokoyama, Toshihide;
    • Seki, Nobuhiko;
    • Ochiai, Ryosuke;
    • Fujimoto, Nobukazu;
    • Murakami, Shuji;
    • Kaira, Kyoichi;
    • Harada, Toshiyuki;
    • Kishino, Daizo;
    • Takiguchi, Yuichi;
    • Shimokawa, Tsuneo;
    • Kiura, Katsuyuki;
    • Yamashita, Natsumi;
    • Okamoto, Hiroaki
    Publication type:
    Article
    9

    More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4933, doi. 10.1007/s00432-022-04415-1
    By:
    • Ando, Chihiro;
    • Ichihara, Eiki;
    • Yokoyama, Toshihide;
    • Inoue, Koji;
    • Tamura, Tomoki;
    • Fujiwara, Keiichi;
    • Oda, Naohiro;
    • Kano, Hirohisa;
    • Kishino, Daizo;
    • Watanabe, Kazuhiko;
    • Inoue, Masaaki;
    • Ochi, Nobuaki;
    • Onishi, Fumie;
    • Ichikawa, Hirohisa;
    • Kobe, Hiroshi;
    • Tachibana, Sayaka;
    • Hotta, Katsuyuki;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    10

    Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2475, doi. 10.1007/s00432-022-04125-8
    By:
    • Hata, Tae;
    • Sakaguchi, Chikara;
    • Hirano, Keita;
    • Kobe, Hiroshi;
    • Ishida, Masaki;
    • Nakano, Takayuki;
    • Tachibana, Yusuke;
    • Tamiya, Nobuyo;
    • Shiotsu, Shinsuke;
    • Takeda, Takayuki;
    • Yamada, Tadaaki;
    • Yokoyama, Toshihide;
    • Tsuchiya, Michiko;
    • Nagasaka, Yukio
    Publication type:
    Article
    11
    12
    13
    14

    A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 327, doi. 10.1159/000501967
    By:
    • Ikeda, Satoshi;
    • Yoshioka, Hiroshige;
    • Kaneda, Toshihiko;
    • Yokoyama, Toshihide;
    • Niwa, Takashi;
    • Sone, Naoyuki;
    • Ishida, Tadashi;
    • Morita, Mitsunori;
    • Tomioka, Hiromi;
    • Komaki, Chihito;
    • Hirabayashi, Masataka;
    • Hasegawa, Yoshinori;
    • Noguchi, Tetsuo;
    • Nakano, Yasutaka;
    • Sakaguchi, Chikara;
    • Yoshimura, Kenichi;
    • Hirai, Toyohiro
    Publication type:
    Article
    15

    Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11417-w
    By:
    • Wakuda, Kazushige;
    • Kenmotsu, Hirotsugu;
    • Sato, Yuki;
    • Nakamura, Atsushi;
    • Akamatsu, Hiroaki;
    • Tachihara, Motoko;
    • Miura, Satoru;
    • Yokoyama, Toshihide;
    • Mori, Keita;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    16
    17

    A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2018, v. 82, n. 6, p. 1031, doi. 10.1007/s00280-018-3694-5
    By:
    • Oda, Naohiro;
    • Hotta, Kastuyuki;
    • Ninomiya, Kiichiro;
    • Minami, Daisuke;
    • Ichihara, Eiki;
    • Murakami, Toshi;
    • Yokoyama, Toshihide;
    • Ichikawa, Hirohisa;
    • Chikamori, Kenichi;
    • Takigawa, Nagio;
    • Ochi, Nobuaki;
    • Harita, Shingo;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    18
    19
    20

    Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221110171
    By:
    • Tsubata, Yukari;
    • Hotta, Takamasa;
    • Hamai, Kosuke;
    • Furuya, Naoki;
    • Yokoyama, Toshihide;
    • Saito, Ryota;
    • Nakamura, Atsushi;
    • Masuda, Takeshi;
    • Hamaguchi, Megumi;
    • Kuyama, Shoichi;
    • Honda, Ryoichi;
    • Senoo, Tadashi;
    • Nakanishi, Masamoto;
    • Yamasaki, Masahiro;
    • Ishikawa, Nobuhisa;
    • Fujitaka, Kazunori;
    • Kubota, Tetsuya;
    • Ohtsu, Hiroshi;
    • Kobayashi, Kunihiko;
    • Isobe, Takeshi
    Publication type:
    Article
    21
    22

    Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 12, p. e2347700, doi. 10.1001/jamanetworkopen.2023.47700
    By:
    • Sakamoto, Tomohiro;
    • Matsubara, Taichi;
    • Takahama, Takayuki;
    • Yokoyama, Toshihide;
    • Nakamura, Atsushi;
    • Tokito, Takaaki;
    • Okamoto, Tatsuro;
    • Akamatsu, Hiroaki;
    • Oki, Masahide;
    • Sato, Yuki;
    • Tobino, Kazunori;
    • Ikeda, Satoshi;
    • Mori, Masahide;
    • Mimura, Chihiro;
    • Maeno, Ken;
    • Miura, Satoru;
    • Harada, Toshiyuki;
    • Nishimura, Kunihiro;
    • Hiraoka, Manabu;
    • Kenmotsu, Hirotsugu
    Publication type:
    Article
    23

    Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 2, p. e230698, doi. 10.1001/jamanetworkopen.2023.0698
    By:
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Tamiya, Motohiro;
    • Hata, Akito;
    • Matsumoto, Hirotaka;
    • Nakamura, Atsushi;
    • Yokoyama, Toshihide;
    • Taniguchi, Yoshihiko;
    • Uchida, Junji;
    • Sato, Yuki;
    • Yokoi, Takashi;
    • Tanaka, Hisashi;
    • Furuya, Naoki;
    • Masuda, Takeshi;
    • Sakata, Yoshihiko;
    • Miyauchi, Eisaku;
    • Hara, Satoshi;
    • Saito, Go;
    • Miura, Satoru;
    • Kanazu, Masaki
    Publication type:
    Article
    24

    Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 4089, doi. 10.3390/cancers16234089
    By:
    • Taoka, Masataka;
    • Ichihara, Eiki;
    • Yokoyama, Toshihide;
    • Inoue, Koji;
    • Tamura, Tomoki;
    • Sato, Akiko;
    • Oda, Naohiro;
    • Kano, Hirohisa;
    • Nakamura, Kayo;
    • Kawai, Haruyuki;
    • Inoue, Masaaki;
    • Ochi, Nobuaki;
    • Fujimoto, Nobukazu;
    • Ichikawa, Hirohisa;
    • Ando, Chihiro;
    • Oze, Isao;
    • Kiura, Katsuyuki;
    • Maeda, Yoshinobu;
    • Hotta, Katsuyuki
    Publication type:
    Article
    25

    The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study.

    Published in:
    Cancers, 2022, v. 14, n. 24, p. 6184, doi. 10.3390/cancers14246184
    By:
    • Nishimura, Tomoka;
    • Ichihara, Eiki;
    • Yokoyama, Toshihide;
    • Inoue, Koji;
    • Tamura, Tomoki;
    • Sato, Ken;
    • Oda, Naohiro;
    • Kano, Hirohisa;
    • Kishino, Daizo;
    • Kawai, Haruyuki;
    • Inoue, Masaaki;
    • Ochi, Nobuaki;
    • Fujimoto, Nobukazu;
    • Ichikawa, Hirohisa;
    • Ando, Chihiro;
    • Hotta, Katsuyuki;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    26
    27

    Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 9, p. 1940, doi. 10.1002/cncr.32749
    By:
    • Takahama, Takayuki;
    • Azuma, Koichi;
    • Shimokawa, Mototsugu;
    • Takeda, Masayuki;
    • Ishii, Hidenobu;
    • Kato, Terufumi;
    • Saito, Haruhiro;
    • Daga, Haruko;
    • Tsuboguchi, Yuko;
    • Okamoto, Isamu;
    • Otsubo, Kohei;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Takahashi, Toshiaki;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Sakai, Kazuko;
    • Yamamoto, Nobuyuki;
    • Nishio, Kazuto
    Publication type:
    Article
    28

    Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

    Published in:
    2020
    By:
    • Takahama, Takayuki;
    • Azuma, Koichi;
    • Shimokawa, Mototsugu;
    • Takeda, Masayuki;
    • Ishii, Hidenobu;
    • Kato, Terufumi;
    • Saito, Haruhiro;
    • Daga, Haruko;
    • Tsuboguchi, Yuko;
    • Okamoto, Isamu;
    • Otsubo, Kohei;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Takahashi, Toshiaki;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Sakai, Kazuko;
    • Yamamoto, Nobuyuki;
    • Nishio, Kazuto
    Publication type:
    journal article
    29
    30

    First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1354, doi. 10.1007/s10147-023-02390-2
    By:
    • Nishio, Makoto;
    • Ohe, Yuichiro;
    • Ikeda, Satoshi;
    • Yokoyama, Toshihide;
    • Hayashi, Hidetoshi;
    • Fukuhara, Tatsuro;
    • Sato, Yuki;
    • Tanaka, Hiroshi;
    • Hotta, Katsuyuki;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Okamoto, Isamu;
    • Kasahara, Kazuo;
    • Naito, Tateaki;
    • Li, Li;
    • Gupta, Ravi G.;
    • Bushong, Judith;
    • Mizutani, Hideaki
    Publication type:
    Article
    31
    32

    Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
    By:
    • Katakami, Nobuyuki;
    • Yokoyama, Toshihide;
    • Morita, Satoshi;
    • Okamoto, Tatsuro;
    • Urata, Yoshiko;
    • Hattori, Yoshihiro;
    • Iwamoto, Yasuo;
    • Sato, Yuki;
    • Ikeda, Norihiko;
    • Takahashi, Toshiaki;
    • Daga, Haruko;
    • Oguri, Tetsuya;
    • Fujisaka, Yasuhito;
    • Nishino, Kazumi;
    • Sugawara, Shunichi;
    • Kozuki, Toshiyuki;
    • Oki, Masahide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    33
    34

    Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 69, doi. 10.1007/s10147-022-02257-y
    By:
    • Tsubata, Yukari;
    • Kawakado, Keita;
    • Hamai, Kosuke;
    • Furuya, Naoki;
    • Yokoyama, Toshihide;
    • Saito, Ryota;
    • Nakamura, Atsushi;
    • Masuda, Takeshi;
    • Hamaguchi, Megumi;
    • Kuyama, Shoichi;
    • Honda, Ryoichi;
    • Senoo, Tadashi;
    • Nakanishi, Masamoto;
    • Hotta, Takamasa;
    • Yamasaki, Masahiro;
    • Ishikawa, Nobuhisa;
    • Fujitaka, Kazunori;
    • Kubota, Tetsuya;
    • Kobayashi, Kunihiko;
    • Isobe, Takeshi
    Publication type:
    Article
    35

    Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7
    By:
    • Sugawara, Shunichi;
    • Kondo, Masashi;
    • Yokoyama, Toshihide;
    • Kumagai, Toru;
    • Nishio, Makoto;
    • Goto, Koichi;
    • Nakagawa, Kazuhiko;
    • Seto, Takashi;
    • Yamamoto, Nobuyuki;
    • Kudou, Kentarou;
    • Asato, Takayuki;
    • Zhang, Pingkuan;
    • Ohe, Yuichiro
    Publication type:
    Article
    36

    Phase I/II Study of Cisplatin plus Nab‐Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 19, doi. 10.1002/ONCO.13524
    By:
    • Hayashi, Hidetoshi;
    • Ogura, Masakazu;
    • Niwa, Takashi;
    • Yokoyama, Toshihide;
    • Tanizaki, Junko;
    • Ozaki, Tomohiro;
    • Yoshioka, Hiroshige;
    • Kurata, Takayasu;
    • Tamura, Yosuke;
    • Fujisaka, Yasuhito;
    • Tanaka, Kaoru;
    • Hasegawa, Yoshikazu;
    • Kudo, Keita;
    • Chiba, Yasutaka;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    37

    Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

    Published in:
    Oncologist, 2019, v. 24, n. 5, p. 593, doi. 10.1634/theoncologist.2019-0003
    By:
    • Nakao, Akira;
    • Hiranuma, Osamu;
    • Uchino, Junji;
    • Sakaguchi, Chikara;
    • Kita, Toshiyuki;
    • Hiraoka, Noriya;
    • Ishizuka, Tamotsu;
    • Kubota, Yutaka;
    • Kawasaki, Masayuki;
    • Goto, Yasuhiro;
    • Imai, Hisao;
    • Hattori, Noboru;
    • Nakatomi, Keita;
    • Uramoto, Hidetaka;
    • Uryu, Kiyoaki;
    • Fukuda, Minoru;
    • Uchida, Yasuki;
    • Yokoyama, Toshihide;
    • Akai, Masaya;
    • Mio, Tadashi
    Publication type:
    Article
    38
    39

    Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single‐plex testing: WJOG13620L.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 23, p. 21097, doi. 10.1002/cam4.6668
    By:
    • Uemura, Takehiro;
    • Kenmotsu, Hirotsugu;
    • Hazama, Daisuke;
    • Teraoka, Shunsuke;
    • Kobe, Hiroshi;
    • Azuma, Koichi;
    • Yamaguchi, Teppei;
    • Masuda, Takeshi;
    • Yokoyama, Toshihide;
    • Otsubo, Kohei;
    • Haratani, Koji;
    • Hayakawa, Daisuke;
    • Oki, Masahide;
    • Takemoto, Shinnosuke;
    • Ozaki, Tomohiro;
    • Akashi, Yusaku;
    • Hata, Akito;
    • Hashimoto, Hiroya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    40

    Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer.

    Published in:
    International Journal of Cancer, 2024, v. 154, n. 9, p. 1607, doi. 10.1002/ijc.34842
    By:
    • Morita, Ayako;
    • Ichihara, Eiki;
    • Inoue, Koji;
    • Fujiwara, Keiichi;
    • Yokoyama, Toshihide;
    • Harada, Daijiro;
    • Ando, Chihiro;
    • Kano, Hirohisa;
    • Oda, Naohiro;
    • Tamura, Tomoki;
    • Ochi, Nobuaki;
    • Kawai, Haruyuki;
    • Inoue, Masaaki;
    • Hara, Naofumi;
    • Fujimoto, Nobukazu;
    • Ichikawa, Hirohisa;
    • Oze, Isao;
    • Hotta, Katsuyuki;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    41

    Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1762, doi. 10.3390/jcm9061762
    By:
    • Nakao, Akira;
    • Hiranuma, Osamu;
    • Uchino, Junji;
    • Sakaguchi, Chikara;
    • Araya, Tomoyuki;
    • Hiraoka, Noriya;
    • Ishizuka, Tamotsu;
    • Takeda, Takayuki;
    • Kawasaki, Masayuki;
    • Goto, Yasuhiro;
    • Imai, Hisao;
    • Hattori, Noboru;
    • Nakatomi, Keita;
    • Uramoto, Hidetaka;
    • Uryu, Kiyoaki;
    • Fukuda, Minoru;
    • Uchida, Yasuki;
    • Yokoyama, Toshihide;
    • Akai, Masaya;
    • Mio, Tadashi
    Publication type:
    Article
    42
    43
    44

    Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 11, p. 1004, doi. 10.1111/1759-7714.14836
    By:
    • Hata, Tae;
    • Sakaguchi, Chikara;
    • Hirano, Keita;
    • Kobe, Hiroshi;
    • Ishida, Masaki;
    • Nakano, Takayuki;
    • Tachibana, Yusuke;
    • Tamiya, Nobuyo;
    • Shiotsu, Shinsuke;
    • Takeda, Takayuki;
    • Yamada, Tadaaki;
    • Yokoyama, Toshihide;
    • Tsuchiya, Michiko;
    • Nagasaka, Yukio
    Publication type:
    Article
    45
    46

    Fatal Immune Checkpoint Inhibitor-related Pancreatitis.

    Published in:
    Internal Medicine, 2021, v. 60, n. 24, p. 3905, doi. 10.2169/internalmedicine.7366-21
    By:
    • Masayuki Ueno;
    • Yoshihisa Tsuji;
    • Toshihide Yokoyama;
    • Takashi Koyama;
    • Yosuke Uenishi;
    • Etsuji Ishida;
    • Motowo Mizuno
    Publication type:
    Article
    47

    Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.

    Published in:
    2021
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Matsumoto, Hirotaka;
    • Hirano, Katsuya;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Tanaka, Satoshi;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Mori, Masahide;
    • Nagata, Kenji
    Publication type:
    journal article
    48

    A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 4, p. 250, doi. 10.1111/ajco.13147
    By:
    • Harada, Daijiro;
    • Kozuki, Toshiyuki;
    • Nogami, Naoyuki;
    • Bessho, Akihiro;
    • Hosokawa, Shinobu;
    • Fukamatsu, Nobuaki;
    • Hotta, Katsuyuki;
    • Ohashi, Kadoaki;
    • Kubo, Toshio;
    • Yoshioka, Hiroshige;
    • Yokoyama, Toshihide;
    • Sone, Naoyuki;
    • Kuyama, Shoichi;
    • Kudo, Kenichiro;
    • Yasugi, Masayuki;
    • Takigawa, Nagio;
    • Oze, Isao;
    • Kiura, Katsuyuki
    Publication type:
    Article
    49
    50